CD8A and neoplasm: Th17 cells mediate anti-tumor response through a dual mechanism: recruiting pro-inflammatory immune cells (macrophages, neutrophils, natural killer (NK) cells, and CD8+ T cells) while reducing immunosuppressive myeloid-derived suppressor cells (MDSCs) [15, 20].